Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, according to a study published in Science Advances. Shana Kelley, Ph.D., ...

Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective T reg cells. These cells help ensure that the ...